We have compared the activation of transcription from the early promoter of simian virus 40 brought about by the enhancer during transient expression in several cell lines. The enhancer stimulated RNA synthesis approximately 400-, 100-, 100-, and 300-fold in human HeLa cells, the mouse plasmacytoma B cells MPC11, and the nondifferentiated and retinoic acid-differentiated mouse embryonal carcinoma F9 cells, respectively. The contribution to enhancer activity of its multiple constituent motifs has been investigated in the different cell types using the pA series of recombinants mutated throughout the enhancer. A comparison of the activity of these recombinants in the four cell lines indicates that the activity of the various enhancer motifs is cell specific. The activity of a given motif in a given cell line correlates well with the known presence in this cell line of a protein(s) that binds specifically to that motif in vitro.
The enhancer of simian virus 40 (SV40) is a cis-acting regulatory element that stimulates transcription in vivo from RNA polymerase class B (II) promoters (refs. 1 and 2; for reviews, see refs. [3] [4] [5] [6] . Enhancer elements have been found associated with a number of cellular and viral genes and may exhibit ubiquitous or cell-specific activity (3) (4) (5) (6) . In vivo studies have shown that the SV40 enhancer consists of multiple sequence motifs that act synergistically to generate enhancer activity in HeLa cells (7, 8) . These sequence motifs GT-II, GT-I, TC-II, Sph I, Sph Il, and P (see Fig. 2 ) are organized in two domains (A and B) whose dimerization generates enhancer activity (7) . The activity of several enhancers including that of SV40 has been partially reproduced in vitro (reviewed in refs. [3] [4] [5] [6] . In vitro "footprinting" studies have shown that each of the sequence motifs of the SV40 enhancer binds a protein(s) present in HeLa cell nuclear extracts (9, 10) . Their binding is prevented by the mutations that are detrimental to enhancer activity in vivo, suggesting that these proteins are the trans-acting factors that mediate enhancer activity in vivo (9) . This idea is further supported by the observation that the overlapping Sph and octamer motifs (see Fig. 2 ) exhibit a cell-specific activity (10) .
These observations led us to suggest (7, 10) that the activity of a given enhancer in a given cell type results from both the nature of its constituent motifs and the presence or absence of the corresponding specific trans-acting factors in that cell type. Thus, the ubiquitous activity of the enhancer may reflect in fact the interaction of its multiple motifs with cell-specific factors. To further investigate the validity of these ideas, we have compared the in vivo activity of the SV40 enhancer motifs in MPC11 mouse plasmacytoma B cells and in nondifferentiated [F9(ND)] and retinoic aciddifferentiated [F9(D)] mouse embryonal carcinoma F9 cells with that previously reported in HeLa cells (7) .
MATERIALS AND METHODS
Recombinant pA0 and the scanning point mutants pAl-pA34 have been described (7) . The scanning point mutants pA-ipA-5 pAlB, and pA24B (see Fig. 2 ) and the "double" mutants pA915, pA1015, pA1115, and pA1215, which contain the mutations present in both pA15 and either pA9, pA10, pAil, or pA12, were constructed by in vitro mutagenesis as described (11) .
All transfections were carried out with the calcium phosphate coprecipitation technique and HeLa cells were grown as described (7) . MPC11 cells and F9 cells were grown in Dulbecco's modified Eagle's minimal essential medium (GIBCO) containing 10% fetal calf serum/500 units of penicillin per ml/400 ,g of gentamycin per ml/100 jig of streptomycin per ml. F9(D) cells were obtained by treatment with retinoic acid (0.1 ,tM) for 4 days before transfection. All other materials and methods were as described (7) . Fig. 1A ). In pAO, which contains the SV40 early promoter inserted upstream of a promoterless ,-globin gene, initiation of transcription occurs exclusively from the SV40 major early-early and minor late-early start sites and the amount of f3-globin RNA synthesized directly reflects the transcriptional activity of the SV40 early promoter ( Fig. 1A ; see ref. 7) . In pA56, the essential enhancer sequences have been deleted (ref. 7 and see below). pG1B, which contains the SV40 enhancer located upstream from the 13-globin promoter, was cotransfected in all experiments to correct for variations in transfection efficiencies. Quantitative S1 nuclease analysis was performed using a 32P S'-end-labeled single-stranded DNA probe, which encompasses the SV40 early promoter and the first 60 base pairs (bp) of the globin sequences and generates hybrids of 130-137 and 60 bp, corresponding to initiation of transcription at the early-early start sites of pA0 or pA56 and at the capsite (+ 1 GLOB) of the reference recombinant pG1B, respectively ( Fig. 1B; . pG1B (12) contains the Pvu II/BamHI fragment of pAO inserted in the Xho I site of a polylinker introduced at position -109 of the 8-globin gene. Some SV40 restriction sites, the 72-bp sequence, the 21-bp repeat region, the "TATA" box, and the early-early (EES) and late-early (LES) start sites are indicated (7). (B) Determination of the stimulation of RNA synthesis brought about by the SV40 enhancer in different cell lines. Increasing amounts of pAO and pA56 (as indicated) were cotransfected with 2 ,ug of pG1B. Cytoplasmic RNA was prepared 40-50 hr after transfection and the amount of RNA initiated at the early-early start sites (EES) of pAO or pA56 and at the start site of the internal reference f3-globin gene (GLOB) was determined by quantitative S1 nuclease analysis using 2.5, 15, and 30 Ag of RNA from HeLa, MPC11, and F9 cells, respectively, and an excess of a single-stranded 32p 5'-end-labeled DNA probe that yields fragments 130-137 and 60 nucleotides long for hybrids corresponding to RNA initiated at the EES and the GLOB start sites, respectively (7) . Autoradiography was for 3 days, 1 week, and 2 weeks for RNA initiated at EES in MPC11, HeLa, and F9 cells, respectively. In the case of HeLa cells, the internal reference gene signal (GLOB) corresponds to a shorter time of exposure (2 days (7) were used to investigate which sequence motifs are responsible for enhancer activity in the four cell types. Since in vitro protein binding studies (13) using nuclear extracts of these cells revealed the existence of a protein, which binds to a sequence extending further upstream than pAl, the activity of five additional mutated recombinants (pA-1-pA-5; Fig. 2 ) was also investigated. Representative autoradiograms are shown in Fig. 1C and the average results ofthree independent transfection experiments in each cell type are summarized in Fig. 2 . An enhancer activity profile very similar to that shown for HeLa cells was obtained in the simian CV1 kidney cell line (data not shown).
As reported (7, 10) , mutations that affect specifically the motifs Sph II and Sph I (pA22, and pA26 and pA27, respectively; Fig. 2 ) were detrimental to enhancer activity in HeLa, but not in MPC11 cells, whereas mutation pA24, The locations of the various enhancer motifs (7) are shown below the sequence (the corresponding nucleotides are boxed). The solid bars "GT-IIA," "GT-IIB," "GT-IIC," "GT-I," and "TC-II" indicate the location of the minimum binding sequences for proteins GT-IIA, -B, and -C (13), GT-IC (14) , and TC-IIA and -B (see text). effect in F9(ND) cells. Similarly, the mutations in pA13 and pA14 decreased enhancer activity only slightly or not at all in HeLa, F9(ND), and F9(D) cells, whereas they had a markedly detrimental effect in MPC11 cells. Note that the mutation present in pA13 resulted in a 50% increase in enhancer activity in F9(ND) cells. The mutation in pA12 caused a striking decrease in activation of transcription in all four cell lines. The other mutations that reside in the GT-I motif (pA10 and pA11) had little effect in HeLa and MPC11 cells, whereas they were detrimental to enhancer activity in F9 cells. This decrease was particularly striking for the F9(ND) cells, where the activity of pA10 and pA11 was reduced to the same extent as that of pA12.
The mutations in pA4, pA5, and pA6, which reside in the GT-II motif, were all detrimental to enhancer activity in HeLa, F9(ND), and F9(D) cells, whereas they had little or no effect in MPC1l cells. Mutations (27) , who found that a multimerized segment containing the Sph and octameric motifs was active in lymphoid B cells but not in HeLa cells, and Ondek et al. (28) , who found the opposite. Some of these discrepancies could be due to the fact that we have studied the activity of these motifs in situ within the SV40 enhancer and not as isolated multimerized motifs.
Four nuclear proteins bind to three sequences A, B, and C, which correspond to or overlap with the GT-II motif (ref. 13 ; Fig. 2 ). Only one of these proteins, protein GT-IIC, whose binding sequence lies entirely within the GT-II motif, exhibits a clear cell specificity (13) (Fig. 1D) . Introducing mutations pA9, pA10, pAll, and pA12 in pA15 (pA915, pA1015, pA1115, and pA1215, respectively) resulted in HeLa cells in a marked decrease in enhancer activity when compared with pA15 alone, whereas no significant decrease was observed in MPC11 cells. Similarly, the activity of pA9-pA15 in F9 cells can be best explained by assuming a competition between proteins GT-IC and TC-IIB, but with protein GT-IC being in excess over TC-IIB, particularly in F9(ND) cells where the enhancer activity of pA9-pA12 was almost identically decreased, while the mutation present in pA15 resulted only in a slight decrease. Note that the marked stimulatory effect of mutation pA13 in F9(ND) cells correlates well with the observation that the binding in vitro of the F9(ND) GT-IC protein to the GT-I sequence is increased severalfold by the A -* C transversions present in pA13 (14) .
In conclusion, the comparison of the present in vivo results with the in vitro binding of cell-specific proteins to the isolated enhancer motifs strongly supports our previous suggestion that different levels of SV40 enhancer activity can be generated in various ways in different cell types as the result of specific combinatorial interactions between cellspecific trans-acting factors and as many as seven motifs that may overlap (7, 9, 10 (31) (32) (33) in the overall activity of the SV40 enhancer. Finally, we note that a SV40-like enhancer organization would be particularly suited to enhancers of cellular genes whose activity is multifactorially regulated in different cell types at various times during development.
